These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22740603)

  • 1. Assessing walking disability in multiple sclerosis.
    Kieseier BC; Pozzilli C
    Mult Scler; 2012 Jul; 18(7):914-24. PubMed ID: 22740603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.
    Skov CD; Sørensen CB; Thorning M; Lambertsen KL; Frich LH; Jensen HB; Holsgaard-Larsen A; Nielsen HH
    Mult Scler Relat Disord; 2022 Oct; 66():104034. PubMed ID: 35843140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    Adusumilli G; Lancia S; Levasseur VA; Amblee V; Orchard M; Wagner JM; Naismith RT
    PLoS One; 2018; 13(6):e0198178. PubMed ID: 29879144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study.
    Dalgas U; Langeskov-Christensen M; Skjerbæk A; Jensen E; Baert I; Romberg A; Santoyo Medina C; Gebara B; Maertens de Noordhout B; Knuts K; Béthoux F; Rasova K; Severijns D; Bibby BM; Kalron A; Norman B; Van Geel F; Wens I; Feys P
    J Neurol Sci; 2018 Apr; 387():179-186. PubMed ID: 29571860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study.
    Kalron A; Ehling R; Baert I; Smedal T; Rasova K; Heric-Mansrud A; Elorriage I; Nedeljkovic U; Tachino A; Gargul L; Gusowski K; Cattaneo D; Borgers S; Hebert J; Dalgas U; Feys P
    Mult Scler Relat Disord; 2020 Nov; 46():102511. PubMed ID: 32949848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.
    Stellmann JP; Vettorazzi E; Poettgen J; Heesen C
    J Neurol Sci; 2014 Nov; 346(1-2):99-106. PubMed ID: 25156343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
    Learmonth YC; Dlugonski DD; Pilutti LA; Sandroff BM; Motl RW
    Mult Scler; 2013 Nov; 19(13):1784-91. PubMed ID: 23587605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set.
    Gijbels D; Dalgas U; Romberg A; de Groot V; Bethoux F; Vaney C; Gebara B; Medina CS; Maamâgi H; Rasova K; de Noordhout BM; Knuts K; Feys P
    Mult Scler; 2012 Mar; 18(3):364-71. PubMed ID: 21952098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerometry as a measure of walking behavior in multiple sclerosis.
    Motl RW; Pilutti L; Sandroff BM; Dlugonski D; Sosnoff JJ; Pula JH
    Acta Neurol Scand; 2013 Jun; 127(6):384-90. PubMed ID: 23240822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R; Pace A; Calay P; Grodent P; Douchamps F; Hyde R; Hotermans C; Delvaux V; Hansen I; Moonen G; Belachew S
    Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-efficacy and walking performance across the lifespan among adults with multiple sclerosis.
    Sikes EM; Cederberg KL; Baird JF; Sandroff BM; Motl RW
    Neurodegener Dis Manag; 2019 Oct; 9(5):267-275. PubMed ID: 31580224
    [No Abstract]   [Full Text] [Related]  

  • 13. The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
    Engelhard MM; Schmidt KM; Engel CE; Brenton JN; Patek SD; Goldman MD
    Qual Life Res; 2016 Dec; 25(12):3221-3230. PubMed ID: 27342237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE; Jiang A; Keller J; Zackowski KM
    Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the 30-Second Sit-to-Stand test as a measure of lower extremity function in persons with multiple sclerosis: Preliminary evidence.
    Zheng P; Huynh TLT; Jones CD; Feasel CD; Jeng B; Motl RW
    Mult Scler Relat Disord; 2023 Mar; 71():104552. PubMed ID: 36774829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between body composition and walking outcomes in multiple sclerosis.
    Jeng B; Motl RW
    Mult Scler Relat Disord; 2022 Dec; 68():104242. PubMed ID: 36274282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The timed 25-foot walk in a large cohort of multiple sclerosis patients.
    Kalinowski A; Cutter G; Bozinov N; Hinman JA; Hittle M; Motl R; Odden M; Nelson LM
    Mult Scler; 2022 Feb; 28(2):289-299. PubMed ID: 34100297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study.
    Baert I; Freeman J; Smedal T; Dalgas U; Romberg A; Kalron A; Conyers H; Elorriaga I; Gebara B; Gumse J; Heric A; Jensen E; Jones K; Knuts K; Maertens de Noordhout B; Martic A; Normann B; Eijnde BO; Rasova K; Santoyo Medina C; Truyens V; Wens I; Feys P
    Neurorehabil Neural Repair; 2014 Sep; 28(7):621-31. PubMed ID: 24503204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of the Timed Up and Go Test as a Measure of Functional Mobility in Persons With Multiple Sclerosis.
    Sebastião E; Sandroff BM; Learmonth YC; Motl RW
    Arch Phys Med Rehabil; 2016 Jul; 97(7):1072-7. PubMed ID: 26944709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Neurology; 2003 Jan; 60(1):31-6. PubMed ID: 12525714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.